1. Home
  2. TACT vs CVRX Comparison

TACT vs CVRX Comparison

Compare TACT & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TransAct Technologies Incorporated

TACT

TransAct Technologies Incorporated

N/A

Current Price

$5.56

Market Cap

46.4M

Sector

Technology

ML Signal

N/A

Logo CVRx Inc.

CVRX

CVRx Inc.

N/A

Current Price

$1.41

Market Cap

37.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TACT
CVRX
Founded
1996
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.4M
37.8M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
TACT
CVRX
Price
$5.56
$1.41
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
★ $4.58
AVG Volume (30 Days)
22.4K
★ 484.2K
Earning Date
11-12-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 87.88
23.02
EPS
★ 0.07
N/A
Revenue
N/A
★ $56,651,000.00
Revenue This Year
$9.17
$3.89
Revenue Next Year
$3.74
$12.45
P/E Ratio
$80.71
★ N/A
Revenue Growth
N/A
★ 10.45
52 Week Low
$3.06
$1.26
52 Week High
$6.02
$11.30

Technical Indicators

Market Signals
Indicator
TACT
CVRX
Relative Strength Index (RSI) 67.19 31.69
Support Level $4.72 $1.26
Resistance Level $6.01 $3.19
Average True Range (ATR) 0.32 0.11
MACD 0.12 0.06
Stochastic Oscillator 88.23 61.70

Price Performance

Historical Comparison
TACT
CVRX

About TACT TransAct Technologies Incorporated

Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

Share on Social Networks: